For the quarter ended April 2026, Agilent Technologies (A Quick QuoteA - Free Report) reported revenue of $1.84 billion, up 10% over the same period last year. EPS came in at $1.49, compared to $1.31 in the year-ago quarter.

The reported revenue represents a surprise of +2.12% over the Zacks Consensus Estimate of $1.8 billion. With the consensus EPS estimate being $1.40, the EPS surprise was +6.21%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Agilent performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Net Revenue- Applied Markets: $344 million versus $320.96 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +14.3% change.
• Net Revenue- Agilent Crosslab Group: $759 million versus $772.99 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +6.5% change.
• Net Revenue- Life Sciences and Diagnostics Markets Segment: $732 million versus the four-analyst average estimate of $702.72 million. The reported number represents a year-over-year change of +11.9%.

View all Key Company Metrics for Agilent here>>>

Shares of Agilent have returned +0.2% over the past month versus the Zacks S&P 500 composite's +5.1% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.